NetworkNewsBreaks

TuesdayFeb 25, 2025 11:52 am

NetworkNewsBreaks – Twin Hospitality Group Inc. (NASDAQ: TWNP) Completes Spinoff from FAT Brands Inc. (NASDAQ: FAT)

Twin Hospitality (NASDAQ: TWNP), the owner of the Twin Peaks and Smokey Bones restaurant brands, has completed its spinoff from FAT Brands (NASDAQ: FAT), a leading global franchising company and parent company of 18 iconic brands. In conjunction with the spin-off, Twin Hospitality Class A Common Stock began trading under the symbol TWNP on the Nasdaq Global Market. Roth Capital Partners acted as financial advisor for the transaction. For more information, visit https://nnw.fm/lptmZ About Twin Peaks Founded in 2005 in the Dallas suburb of Lewisville, Twin Peaks franchises and owns 115 restaurants in the United States and Mexico. Twin Peaks…

Continue Reading

TuesdayFeb 25, 2025 9:55 am

NetworkNewsBreaks – GivBux Inc. (GBUX) Approves Special Dividend Warrant Issuance

GivBux (OTC: GBUX) announced that its Board of Directors approved a special dividend for shareholders in the form of warrants, authorizing a 1-for-10 warrant issuance that will allow the purchase of additional common stock at a price to be determined later. The dividend underscores the company’s commitment to rewarding loyal shareholders and enabling participation in future growth as it scales its Super App platform globally, said President Umesh Tim Singh. Pricing details and the warrant exercise period will be provided in future communications. To view the full press release, visit https://nnw.fm/YqpiO About GivBux Inc. The GivBux Super App revolutionizes shopping…

Continue Reading

TuesdayFeb 25, 2025 9:30 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) database in FDA-recommended analyses of CNM-Au8® for treating amyotrophic lateral sclerosis (ALS). APST's repository includes biomarker data from over 4,300 ALS patients, which will help Clene compare NfL changes in NIH-sponsored Expanded Access Protocol participants to matched controls. The results could support Clene’s planned New Drug Application submission for CNM-Au8 under the FDA's Accelerated Approval pathway in the second half of 2025. CEO Rob Etherington emphasized the importance of leveraging real-world evidence to advance potential treatments for ALS. To view…

Continue Reading

TuesdayFeb 25, 2025 9:20 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Investment in Mozambican Football Club Black Bulls

Brera Holdings (NASDAQ: BREA) and Lalgy Transport have signed a Letter of Intent to expand their investment in Mozambique’s Black Bulls, the reigning Mocambola league champion. Under the agreement, Brera will become a co-owner of the club, reinforcing its mission to develop African football talent and create global pathways for players. The partnership will see Brera and Mr. Lalgy collaborate to enhance the competitiveness of Mozambican football, particularly in European markets. As part of this strategy, Brera Tchumene FC will pause its independent operations to align efforts with Black Bulls, optimizing resources for long-term growth. To view the full press…

Continue Reading

MondayFeb 24, 2025 3:32 pm

NetworkNewsBreaks – Mandalay Resources Corporation (TSX: MND) (OTCQB: MNDJF) Achieves Record Financial Performance, Milestone Year in 2024

Mandalay (TSX: MND) (OTCQB: MNDJF) recently announced its financial results for the fourth quarter and year ended Dec. 31, 2024. Among the highlights, the company reported record revenue and significant cash flow growth, attributed to its commitment to operational excellence and financial discipline. “2024 was a milestone year for Mandalay, marked by record financial performance and substantial earnings growth. Our strategic emphasis on higher-margin production, cost efficiency, and operational improvements have delivered outstanding results,” said Frazer Bourchier, Mandalay’s president and CEO. “With a strong cash position, zero debt, and an ongoing commitment to sustainable cash generation, we enter 2025 well-prepared…

Continue Reading

MondayFeb 24, 2025 3:21 pm

NetworkNewsBreaks – AiEnglishGPT Featured in Bell2Bell Podcast

AiEnglishGPT, an AI-driven platform providing personalized, real-time language and professional skills instruction across 64 languages, was featured in the latest episode of the Bell2Bell Podcast, as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Mark Emerson, president and CEO of AiEnglishGPT, joined the program to discuss the company’s business model and its plans to address needs in both B2C and enterprise markets. “We are breakthrough technology for education. We’ve created what we call the super teachers – synthetic humans that look very lifelike and have a ton of content knowledge. They become your personal…

Continue Reading

MondayFeb 24, 2025 1:55 pm

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Collaborate on Hybrid Generation Solar Project in Buffalo

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in an article published by Buffalo Business First. The piece highlights SolarBank’s collaboration with Viridi on a proposed $7 billion solar project at a former landfill in South Buffalo, which would include 3.06 megawatts of solar generation and 1.2 megawatt-hours of battery storage. While relatively rare, these hybrid generation projects are becoming more common according to Matthew McGregor, senior developer of U.S.…

Continue Reading

MondayFeb 24, 2025 10:10 am

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) to Present Gochager Lake Drill Core at PDAC Core Shack

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) announced it will present drill core from its Gochager Lake project at the PDAC Core Shack March 4-5, 2025. The Company invites PDAC attendees to visit booth #3113B to view GL23003 drill core and meet management to discuss the project and exploration plans. To view the full press release, visit: https://nnw.fm/2RFhH About Fathom Nickel Inc. Fathom is a junior exploration company focused on exploring for and developing world class nickel camps in the province of Saskatchewan. NOTE TO INVESTORS: The latest news and updates relating to FNICF are available in the company’s newsroom…

Continue Reading

MondayFeb 24, 2025 10:05 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Attend FT Business of Football Summit in London

Brera Holdings (NASDAQ: BREA) an Ireland-based Nasdaq-listed international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership ("MCO") model, said its Executive Chairman Daniel McClory and Head of Investments Maria Xing will attend the Financial Times Business of Football Summit Feb. 26-27, 2025 at The Peninsula Hotel in London. The event gathers more than 700 investors, club and league executives, regulators, broadcasters and tech innovators and features speakers including Todd Boehly of Eldridge Industries and Chelsea FC; Stephen Pagliuca of Bain Capital and Atalanta BC; Mark Attanasio of Crescent Capital Group;…

Continue Reading

MondayFeb 24, 2025 9:23 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Launches “CLD-101” Trial for High-Grade Glioma at Northwestern

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted antitumor virotherapies, said Northwestern University/Northwestern Memorial Hospital is recruiting for its Phase 1B/2 clinical trial of "CLD-101" in newly diagnosed high-grade glioma patients. The company completed shipment of the first batch of CLD-101—comprising allogeneic neural stem cells loaded with the oncolytic adenovirus CRAd-S-pk7—to support the trial, which builds on promising Phase 1 results in 12 patients published in The Lancet Oncology. The physician-led and NCI-sponsored study, headed by Dr Maciej Lesniak and Dr Roger Stupp and funded by the NIH/NCI SPORE, aims to evaluate a multiple-dose regimen that could…

Continue Reading